James W. Newman Jr. insider trades

Open-market stock purchases and sales by James W. Newman Jr., Director at Adial Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 31, 2018.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ADIL Adial Pharmaceuticals, Inc: 7 buys, last May 29, 2025

Get free alerts when James W. Newman Jr. files a new trade →